Disclosures for "First Medications Prescribed for Acute Treatment or Prevention of Migraine Among Newly Diagnosed Adult Patients in the US: A Comparison of Neurologists vs. Primary Care Providers"
-
Dr. CohenA has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. CohenA has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. CohenA has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pfizer . Dr. CohenA has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. CohenA has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly. Dr. CohenA has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Headache. Dr. CohenA has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Reports. Dr. CohenA has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Varlack Legal.
-
Dr. Martin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Martin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Martin has received research support from Amgen. The institution of Dr. Martin has received research support from Eli Lilly. The institution of Dr. Martin has received research support from Teva. The institution of Dr. Martin has received research support from Abbvie. Dr. Martin has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Patel has stock in Pfizer Inc.
-
Mrs. Tellor has received personal compensation for serving as an employee of Pfizer. Mrs. Tellor has stock in Pfizer.
-
Dr. Fajardo has nothing to disclose.
-
Mr. Hayflinger has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Pfizer.
-
Dr. Corman has nothing to disclose.
-
Dr. Dagenais has received personal compensation for serving as an employee of Pfizer, Inc.. Dr. Dagenais has stock in Pfizer, Inc.. Dr. Dagenais has received publishing royalties from a publication relating to health care.